We feature Medizone International Inc (OTC BB: MZEI), a specialty pharmaceuticals company, as today’s top momentum gainer since the stock gained more than 14% touching its 52-week highs during the last two consecutive trading days with huge number of shares exchanging hands. During the last session, MZEI was the top gainers in the U.S. healthcare sector after gaining 15.6% and closed at its 52-week high of $0.23 while recording significant volumes of 1.1 million shares. During the past 5 trading sessions, MZEI gained 32.6% with daily average traded volumes of 411,697 shares, while the stock accumulated over 49% during the past one month with daily average volume of 541,426 million shares.
Company Description:
Medizone International Inc (OTC BB: MZEI) researches and develops ozone based treatment for diseases and health problems caused by lipid enveloped viruses such as Hepatitus B. The company is also developing technology for the decontamination of blood, blood products, and veterinarian serum products.
1-Year Stock Chart:
Source: Bloomberg
